AAAAAA

   
Results: 1-10 |
Results: 10
Superantigens: The good, the bad, and the ugly
Authors: Torres, BA Kominsky, S Perrin, GQ Hobeika, AC Johnson, HM
Citation: Ba. Torres et al., Superantigens: The good, the bad, and the ugly, EXP BIOL ME, 226(3), 2001, pp. 164-176
Surrogate markers of response to cancer immunotherapy
Authors: Morse, MA Clay, TM Hobeika, AC Mosca, PJ Lyerly, HK
Citation: Ma. Morse et al., Surrogate markers of response to cancer immunotherapy, EXPERT OP B, 1(2), 2001, pp. 153-158
Assays for monitoring cellular immune responses to active immunotherapy ofcancer
Authors: Clay, TM Hobeika, AC Mosca, PJ Lyerly, HK Morse, MA
Citation: Tm. Clay et al., Assays for monitoring cellular immune responses to active immunotherapy ofcancer, CLIN CANC R, 7(5), 2001, pp. 1127-1135
Quantitating therapeutically relevant T-cell responses to cancer vaccines
Authors: Hobeika, AC Clay, TM Mosca, PJ Lyerly, HK Morse, MA
Citation: Ac. Hobeika et al., Quantitating therapeutically relevant T-cell responses to cancer vaccines, CR R IMMUN, 21(1-3), 2001, pp. 287-297
Direct detection of cellular immune responses to cancer vaccines
Authors: Mosca, PJ Hobeika, AC Clay, TM Morse, MA Lyerly, HK
Citation: Pj. Mosca et al., Direct detection of cellular immune responses to cancer vaccines, SURGERY, 129(3), 2001, pp. 248-254
Superantigen enhanced protection against a weak tumor-specific melanoma antigen: Implications for prophylactic vaccination against cancer
Authors: Kominsky, SL Torres, BA Hobeika, AC Lake, FA Johnson, HM
Citation: Sl. Kominsky et al., Superantigen enhanced protection against a weak tumor-specific melanoma antigen: Implications for prophylactic vaccination against cancer, INT J CANC, 94(6), 2001, pp. 834-841
Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells
Authors: Kominsky, SL Hobeika, AC Lake, FA Torres, BA Johnson, HM
Citation: Sl. Kominsky et al., Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells, CANCER RES, 60(14), 2000, pp. 3904-3908
A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 Ligand and interferon-gamma treatment
Authors: Mosca, PJ Hobeika, AC Clay, TM Nair, SK Thomas, EK Morse, MA Lyerly, HK
Citation: Pj. Mosca et al., A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 Ligand and interferon-gamma treatment, BLOOD, 96(10), 2000, pp. 3499-3504
IFN-gamma induction of p21(WAF1) is required for cell cycle inhibition andsuppression of apoptosis
Authors: Hobeika, AC Etienne, W Torres, BA Johnson, HM Subramaniam, PS
Citation: Ac. Hobeika et al., IFN-gamma induction of p21(WAF1) is required for cell cycle inhibition andsuppression of apoptosis, J INTERF CY, 19(12), 1999, pp. 1351-1361
IFN gamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21(WAF1/CIP1)
Authors: Kominsky, S Johnson, HM Bryan, G Tanabe, T Hobeika, AC Subramaniam, PS Torres, B
Citation: S. Kominsky et al., IFN gamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21(WAF1/CIP1), ONCOGENE, 17(23), 1998, pp. 2973-2979
Risultati: 1-10 |